Literature DB >> 34085420

The Importance of Arrhythmia Burden for Outcomes and Management Related to Catheter Ablation of Atrial Fibrillation.

Paula Sánchez-Somonte1, Enes Elvin Gul1, Atul Verma2.   

Abstract

Atrial fibrillation (AF) ablation has been shown to be an effective treatment for AF, although our understanding of AF ablation outcomes until now, has been based on AF recurrence as a dichotomous variable. Reduction in AF burden, defined as the proportion of time that an individual is in AF during a monitoring period, has been already correlated to an improvement in quality of life and is likely a better assessment of success. Clinically, many patients may still have a few short recurrences of AF but feel much better. In addition, several studies have related higher AF burden with poorer health outcomes and a higher risk of stroke. Despite the growing understanding of AF burden, it is not clear yet which threshold of AF burden would be considered an appropriate outcome measure for AF ablation. Further investigations are needed to address that question. However, the reduction of AF burden seems to be a more accurate reflection of procedural success and a better predictor of prognosis and stroke risk than a single measure of AF.
Copyright © 2021. The Korean Society of Cardiology.

Entities:  

Keywords:  AF ablation; AF burden; Prognosis; Quality of life; Stroke

Year:  2021        PMID: 34085420     DOI: 10.4070/kcj.2021.0077

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


  3 in total

1.  Rare and Elusive Arrhythmia: Atrial Tachycardia From Noncoronary Aortic Cusp During Catheter Ablation for Atrial Fibrillation.

Authors:  Jae-Sun Uhm
Journal:  Korean Circ J       Date:  2022-07       Impact factor: 3.101

2.  What Is Better Predictor of Late Recurrence after Radiofrequency Catheter Ablation for Atrial Fibrillation?

Authors:  Sung Il Im; Kyoung-Min Park
Journal:  Korean Circ J       Date:  2022-05       Impact factor: 3.101

3.  Accuracy of atrial fibrillation detection by an insertable cardiac monitor in patients undergoing catheter ablation: Results of the BioVAD study.

Authors:  Amira Assaf; Dominic A M J Theuns; Rafi Sakhi; Rohit E Bhagwandien; Tamas Szili-Torok; Sing-Chien Yap
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-04-28       Impact factor: 1.485

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.